Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kingboard Holdings Limited is a prominent Hong Kong-based conglomerate primarily known for its global leadership in the manufacture of laminates and printed circuit boards. Beyond its electronics core, the group operates a robust chemical division that produces a wide range of industrial chemicals and pharmaceutical intermediates. Its pharmaceutical subsidiary, Kingboard (Lianzhou) Pharmaceutical Co., Ltd., is a significant manufacturer of active pharmaceutical ingredients (APIs), specifically focusing on the penicillin family. The company is a major global supplier of 6-aminopenicillanic acid (6-APA), amoxicillin, and ampicillin. By leveraging its vertical integration in chemical production, Kingboard maintains a competitive position in the global supply chain for essential antibiotics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kingboard Group.